4//SEC Filing
Humphrey Jeffrey 4
Accession 0000899243-21-038823
CIK 0001690585other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:34 PM ET
Size
5.5 KB
Accession
0000899243-21-038823
Insider Transaction Report
Form 4
Humphrey Jeffrey
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-01+275,000→ 275,000 totalExercise: $7.51Exp: 2031-09-30→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on October 1, 2022, and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001816944
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:34 PM ET
- Size
- 5.5 KB